Dow Jones ends higher on defense rebound as tech drags; Friday jobs report looms

Dow Jones ends higher on defense rebound as tech drags; Friday jobs report looms

New York, Jan 8, 2026, 17:06 EST — After-hours

  • The Dow closed up 270 points as defense names rebounded on Trump’s budget comments
  • Tech slid, pushing the Nasdaq lower even as the S&P 500 finished flat
  • Traders now turn to Friday’s U.S. payrolls report and the start of big-bank earnings next week

The Dow Jones Industrial Average ended higher on Thursday, lifted by a rebound in defense stocks after President Donald Trump called for a sharply larger U.S. military budget. The Dow rose 270.03 points, or 0.55%, to 49,266.11; the S&P 500 edged up 0.01% and the Nasdaq fell 0.44%. 1

The market is trying to price two messages at once: a bigger spending push that could fatten defense backlogs, and a tougher line on contractors’ shareholder payouts. Trump said the 2027 military budget should be $1.5 trillion, versus $901 billion approved by Congress for 2026, though any increase would need lawmakers’ sign-off. 2

Rates traders also kept one eye on the data after a stretch of disrupted releases tied to last year’s long government shutdown. Weekly jobless claims rose 8,000 to 208,000, while a Reuters survey showed economists expect December payroll growth of 60,000 and an unemployment rate of 4.5%. “Firms are successfully doing more with less labor,” said Matthew Martin, senior U.S. economist at Oxford Economics. 3

Defense shares snapped back after Wednesday’s slide, with investors leaning on the idea that more spending would outweigh tighter rules on buybacks and dividends. Morgan Stanley analysts led by Kristine Liwag wrote: “A limit on capital return is an incremental negative, but the size is manageable.” 4

Still, Trump’s executive order raised the stakes for the sector. The order said contractors would be barred from dividends and stock buybacks until they deliver “on time and on budget,” and it directed Pentagon chief Pete Hegseth to identify underperforming firms within 30 days, with changes to future contracts to follow. 5

Technology weighed, with Nvidia down 2.2%, Broadcom off 3.2% and Microsoft down 1.1%, as investors grew pickier on AI-linked names. “While AI is still hot, there are going to be winners and losers,” said Art Hogan, chief market strategist at B. Riley Wealth. 6

Within the Dow, Home Depot and Sherwin-Williams did much of the heavy lifting, a reminder that the index is price-weighted — higher-priced stocks move it more. Home Depot rose $12.74 and Sherwin-Williams gained $9.59, together contributing about 137 points to the Dow’s advance, with Nike, Coca-Cola and Procter & Gamble also helping, MarketWatch reported. 7

Company headlines also kept a pulse on the index. JPMorgan Chase and Apple said the bank will become the new issuer of the Apple Card, replacing Goldman Sachs, in a deal expected to transfer more than $20 billion of card balances once completed; Goldman CEO David Solomon said the move “substantially completes” the narrowing of the firm’s consumer focus. 8

But the path into Friday looks messy: a big policy-driven bid for defense can collide with budget math and congressional friction, and a hot jobs print could push yields up again. Valuations are still “relatively pricey” heading into earnings season, with the S&P 500 trading around 22 times expected earnings — a price-to-earnings ratio — above its five-year average of 19, according to LSEG data. 9

Next up is Friday’s U.S. employment report for December — the nonfarm payrolls count, which excludes farm workers — due at 8:30 a.m. ET. Earnings season then starts to bite next week, with JPMorgan set for Jan. 13 and Goldman Sachs on Jan. 15. 10

Stock Market Today

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

7 February 2026
SSE shares closed Friday at 2,510p, up 1.2%, with about 6.6 million shares traded. The company’s transmission arm secured over £6.9 million in Ofgem innovation funding for four projects. Investors adjusted UK rate-cut bets after a split Bank of England decision. SSE maintained 2025/26 earnings guidance and reported a 7% rise in renewables output.
Iberia flight IB569 to Paris ends up at Luton after rare double diversion in snow-hit Europe
Previous Story

Iberia flight IB569 to Paris ends up at Luton after rare double diversion in snow-hit Europe

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials
Next Story

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

Go toTop